ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671765 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671765; 2) Community: the network communities that were significantly associated with the response to NSC 671765; 3) Molecule: the relationships between components within communities and NSC 671765; 4) MDR: the compounds that were significantly associated with the NSC 671765.

NSC Compound Enrichment Correlation
NSC 626874 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride 0.0385613993886001 0.53543216
NSC 628591 Null 0.0385613993886001 0.13202712
NSC 633273 ANTINEOPLASTIC-633273 0.0385613993886001 0.2145745
NSC 633685 9-N-(N'-chloroethyl-N'-1,6-diaminohexyl) 2-methoxyacridine, dihydrochloride 0.0385613993886001 0.22115378
NSC 637126 Null 0.0385613993886001 0.24101167
NSC 638038 Null 0.0385613993886001 0.13568219
NSC 638635 Propyl-1-aminium, 3-[3,5-bis(phenylmethylene)-4-oxo- piperidin-1-yl]-3-oxo-N,N,N-trimethyl-, bromide 0.0385613993886001 0.27448086
NSC 639516 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride 0.0385613993886001 0.3207502
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0385613993886001 0.36047065
NSC 645389 Null 0.0385613993886001 0.3406497
Total:130  Current:106    [First] [Prev] [Next] [Last]